Published by AmerisourceBergen:

“Direct and indirect remuneration (DIR) fees are wreaking havoc on balance sheets across community pharmacies, with many asking what can be done right now. It is reasonable to expect that pharmacy reimbursements are fair, accurate and timely, yet DIR fees are misleading, confusing and retroactive. This lack of transparency, as well as the resulting instability, threatens the viability of independent community pharmacies — and impacts patient access to medication.”